fbpx

Investors

Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)

ASX Announcements

Opyl delivers world-first in mapping and linking global clinical trial outcome data

download

Opyl receives $570K R&D tax refund

download

Clarification to ASX announcement of 28 September 2022

download

Opin forms strategic partnership and new services for better clinical trial outcomes and scale

download

Opyl Full Year FY22 Results Announcement

download

Opyl partners with leading patient advocate groups

download

Investor Presentations

AGM 2022 Presentation

download

AGM 2021 Presentation

download

Investor Update August 2021 Presentation

download

Investors Update May 2021 Morgans Business Breakfast

download

Half Year 2021 Presentation

download

AGM 2020 Presentation

download

Quarterly Reports

Opyl Appendix 4C – Quarter (Q1) ending 30 September 2022

download

Opyl Appendix 4C – Quarter (Q4) ending 30 June 2022

download

Opyl Appendix 4C – Quarter (Q3) ending 31 March 2022

download

Opyl Appendix 4D – Half-year ending 31 December 2021

download

Opyl Appendix 4C – Quarter (Q2) ending 31 December 2021

download

Opyl Appendix 4C – Quarter (Q1) ending 30 September 2021

download

Annual Reports

Opyl 2022 Annual Report

download

Opyl 2021 Annual Report

download

Opyl 2020 Annual Report

download

Corporate Governance

Opyl – Corporate Governance Statement 2022

download

Opyl – Constitution 2022

download

Opyl – Audit and Risk Committee Charter 2020

download

Opyl – Board Charter 2020

download

Opyl – Code of Conduct 2020

download

Opyl – Diversity Policy 2020

download

Opyl – Remuneration and Nomination Committee Charter 2020

download

Opyl – Trading Policy 2020

download

Opyl – Whistleblower 2020

download

Opyl – Disclosure and Communication Policy 2020

download

Opyl – Appendix 4G

download

Board and Management Team

Mark Ziirsen

Chairman

Michelle Gallaher

Chief Executive Officer

Damon Rasheed

Executive Director

Dr Julian Chick

Non Executive Director

Dr Megan Robertson

Non Executive Director

David Iilja

Company Secretary